Real-World Effectiveness and Pharmacogenetics of Belzutifan in VHL Syndrome: The BELIEVE-VHL Trial

Clinical trial NCT07167329 · RECRUITING

Trial details

NCT number: NCT07167329
Sponsor: José Claudio Casali da Rocha
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Von Hippel Lindau Von Hippel Lindau Disease Von Hippel Lindau-Deficient Clear Cell Renal Cell Carcinoma Hemangioblastoma (HB) of the Central Nervous System (CNS)PNET Retinal Angiomatous Proliferation Pheochromocytoma/Paraganglioma Endolymphatic Sac Tumor

Start date: 2024-01-01
Primary completion: 2026-02-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.